AgriLabs this week released its reformulated, USDA-licensed Colostrx, a colostrum replacer and supplement designed to ensure calves receive valuable immunity and antibodies.
The next generation of Colostrx CS and Colostrx CR has a USDA dual-claim to aid in the treatment of passive transfer (FPT) of immunity and to aid in the prevention of death associated with Escherichia coli K99 in colostrum-deprived neonatal calves.
USDA-licensed Colostrx products are specially formulated with true maternal bovine colostrum from U.S. Grade A dairies, says Adam Yankowsky, AgriLabs business unit manager. "They're complete with essential first-day bioactive components, proteins and antibodies, which newborn calves must receive," he said.
A recent nationwide evaluation on the quality of colostrum found almost 60% of maternal colostrum on farms is inadequate. It also found nearly 45% of all colostrum fed to calves contained enough pathogenic threats to endanger calf health.
Calves experiencing FPT or receiving inadequate concentrations of IgG antibodies are more likely to lack vigor, have diminished performance, be unable to compensate adequately for stress, as well as being at risk for increased mortality or morbidity, AgriLabs notes.
Colostrx CS and Colostrx CR are tested to be antibiotic-free, synthetic hormone-free and pathogen-free. These products deliver 50 and 100 grams of bovine origin IgG and a full natural dose of E. coli K99 antibody with each feeding.